预防腹部外科手术后腹腔粘连的中国专家共识

2017-11-30 中国普通外科相关专家组(统称) 中华普通外科杂志.2017.32(11):984-9883

腹腔内粘连可分为原发性和继发性两种。继发性粘连源于腹腔内炎症、放射和手术损伤导致的腹膜炎症反应。术后粘连是指手术所造成的脏器、组织创伤修复过程中形成的异常纤维连接,是腹部、盆腔外科手术术后最为常见的并发症。根据术后粘连部位和涉及脏器、组织的不同,粘连可保持“静止”而无任何临床症状,或引起严重的并发症,重者可导致急性肠梗阻、肠绞窄乃至危及患者生命。因此,制定符合我国实际情况的预防腹部外科术后腹腔粘连

中文标题:

预防腹部外科手术后腹腔粘连的中国专家共识

发布日期:

2017-11-30

简要介绍:

腹腔内粘连可分为原发性和继发性两种。继发性粘连源于腹腔内炎症、放射和手术损伤导致的腹膜炎症反应。术后粘连是指手术所造成的脏器、组织创伤修复过程中形成的异常纤维连接,是腹部、盆腔外科手术术后最为常见的并发症。根据术后粘连部位和涉及脏器、组织的不同,粘连可保持“静止”而无任何临床症状,或引起严重的并发症,重者可导致急性肠梗阻、肠绞窄乃至危及患者生命。因此,制定符合我国实际情况的预防腹部外科术后腹腔粘连的专家共识具有十分重要的临床意义。

 

拓展指南:腹腔粘连相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=预防腹部外科手术后腹腔粘连的中国专家共识)] GetToolGuiderByIdResponse(projectId=1, id=2ea5d1c00153e51a, title=预防腹部外科手术后腹腔粘连的中国专家共识, enTitle=, guiderFrom=中华普通外科杂志.2017.32(11):984-9883, authorId=null, author=, summary=腹腔内粘连可分为原发性和继发性两种。继发性粘连源于腹腔内炎症、放射和手术损伤导致的腹膜炎症反应。术后粘连是指手术所造成的脏器、组织创伤修复过程中形成的异常纤维连接,是腹部、盆腔外科手术术后最为常见的并发症。根据术后粘连部位和涉及脏器、组织的不同,粘连可保持“静止”而无任何临床症状,或引起严重的并发症,重者可导致急性肠梗阻、肠绞窄乃至危及患者生命。因此,制定符合我国实际情况的预防腹部外科术后腹腔粘连, cover=, journalId=null, articlesId=null, associationId=1261, associationName=中国普通外科相关专家组(统称), associationIntro=, copyright=0, guiderPublishedTime=Thu Nov 30 00:00:00 CST 2017, originalUrl=, linkOutUrl=, content=<P>腹腔内粘连可分为原发性和继发性两种。继发性粘连源于腹腔内炎症、放射和手术损伤导致的腹膜炎症反应。术后粘连是指手术所造成的脏器、组织创伤修复过程中形成的异常纤维连接,是腹部、盆腔外科手术术后最为常见的并发症。根据术后粘连部位和涉及脏器、组织的不同,粘连可保持“静止”而无任何临床症状,或引起严重的并发症,重者可导致急性肠梗阻、肠绞窄乃至危及患者生命。因此,制定符合我国实际情况的预防腹部外科术后腹腔粘连的专家共识具有十分重要的临床意义。 </P> <P> </P>拓展指南:<strong>与<font color=red>腹腔粘连</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=7d74a1c0013e388a" title="2015预防妇产科手术后盆腹腔粘连的中国专家共识" target=_blank>2015预防妇产科手术后盆腹腔粘连的中国专家共识</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E8%85%B9%E8%85%94%E7%B2%98%E8%BF%9E" target=_blank>有关腹腔粘连更多指南</a></ul>, tagList=[TagDto(tagId=60585, tagName=腹部外科), TagDto(tagId=22726, tagName=腹腔粘连)], categoryList=[CategoryDto(categoryId=23, categoryName=普通外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7030, appHits=311, showAppHits=0, pcHits=4575, showPcHits=3339, likes=127, shares=15, comments=5, approvalStatus=1, publishedTime=Fri Dec 29 16:12:45 CST 2017, publishedTimeString=2017-11-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Fri Dec 29 16:12:45 CST 2017, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 11:28:43 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=预防腹部外科手术后腹腔粘连的中国专家共识)])
预防腹部外科手术后腹腔粘连的中国专家共识
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=275113, encodeId=fb282e51130d, content=创新治疗方法.学习了., beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Wed Jan 03 18:51:05 CST 2018, time=2018-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=274534, encodeId=c7eb2e453470, content=henhao, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=b10c1938054, createdName=1e0e5697m83(暂无匿称), createdTime=Mon Jan 01 16:14:43 CST 2018, time=2018-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=274161, encodeId=a8d22e4161fc, content=henhao, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=80d11516357, createdName=139****0239, createdTime=Sun Dec 31 11:07:53 CST 2017, time=2017-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=273570, encodeId=dab02e3570e3, content=henhao, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=353a2047758, createdName=137****9095, createdTime=Fri Dec 29 17:24:49 CST 2017, time=2017-12-29, status=1, ipAttribution=)]
    2018-01-03 虈亣靌

    创新治疗方法.学习了.

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=275113, encodeId=fb282e51130d, content=创新治疗方法.学习了., beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Wed Jan 03 18:51:05 CST 2018, time=2018-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=274534, encodeId=c7eb2e453470, content=henhao, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=b10c1938054, createdName=1e0e5697m83(暂无匿称), createdTime=Mon Jan 01 16:14:43 CST 2018, time=2018-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=274161, encodeId=a8d22e4161fc, content=henhao, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=80d11516357, createdName=139****0239, createdTime=Sun Dec 31 11:07:53 CST 2017, time=2017-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=273570, encodeId=dab02e3570e3, content=henhao, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=353a2047758, createdName=137****9095, createdTime=Fri Dec 29 17:24:49 CST 2017, time=2017-12-29, status=1, ipAttribution=)]
    2018-01-01 1e0e5697m83(暂无匿称)

    henhao

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=275113, encodeId=fb282e51130d, content=创新治疗方法.学习了., beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Wed Jan 03 18:51:05 CST 2018, time=2018-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=274534, encodeId=c7eb2e453470, content=henhao, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=b10c1938054, createdName=1e0e5697m83(暂无匿称), createdTime=Mon Jan 01 16:14:43 CST 2018, time=2018-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=274161, encodeId=a8d22e4161fc, content=henhao, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=80d11516357, createdName=139****0239, createdTime=Sun Dec 31 11:07:53 CST 2017, time=2017-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=273570, encodeId=dab02e3570e3, content=henhao, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=353a2047758, createdName=137****9095, createdTime=Fri Dec 29 17:24:49 CST 2017, time=2017-12-29, status=1, ipAttribution=)]
    2017-12-31 139****0239

    henhao

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=275113, encodeId=fb282e51130d, content=创新治疗方法.学习了., beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Wed Jan 03 18:51:05 CST 2018, time=2018-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=274534, encodeId=c7eb2e453470, content=henhao, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=b10c1938054, createdName=1e0e5697m83(暂无匿称), createdTime=Mon Jan 01 16:14:43 CST 2018, time=2018-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=274161, encodeId=a8d22e4161fc, content=henhao, beContent=null, objectType=guider, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=80d11516357, createdName=139****0239, createdTime=Sun Dec 31 11:07:53 CST 2017, time=2017-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=273570, encodeId=dab02e3570e3, content=henhao, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NcXNhUvfhzd2VdicMnaLeK2Im5gKx4Ucxd8Bwu6S7RG0uILBFQx5HTW2bU4VricDYlQqN20ibASSMYAeGrZrrTpy2Q/0, createdBy=353a2047758, createdName=137****9095, createdTime=Fri Dec 29 17:24:49 CST 2017, time=2017-12-29, status=1, ipAttribution=)]
    2017-12-29 137****9095

    henhao

    0